Trial Evaluating Three Fixed Dosages of Paliperidone Extended-Release (ER) Tablets and Olanzapine in the Treatment of Patients With Schizophrenia

This study has been completed.

Study NCT00078039 Information provided by Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

First Received: February 17, 2004 Last Updated: March 24, 2008 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Study Completion Date:	January 2005
Estimated Primary Completion Date:	No date given